NLS Pharmaceutics and Kadimastem Form Strategic Alliance to Boost Gene-Edited Therapies NLS Pharmaceutics and Kadimastem's collaboration with TargetGene aims to advance next-gen gene-edited cell therapies for chronic diseases, including ALS.

NLS Pharmaceutics and Kadimastem Form Strategic Alliance to Boost Gene-Edited Therapies #Switzerland #NLS_Pharmaceutics #Zurich #Kadimastem #TargetGene